Guided by the unique and unmet needs identified by patients with metastatic breast cancer (MBC) and their families, Pfizer Canada and Rethink Breast Cancer have committed to funding an e-IMPAQc project for patients with MBC.

There are many experiences affecting women with MBC that impact their ability to manage their care or capacity to plan for the future. The systematic screening of patients’ symptoms and the challenges they face, also referred to as patient-reported outcomes or PROs, is a cornerstone of high-quality cancer care and can serve as a tool to improve patients’ lives. The goal of this program is to implement an electronic patient-reported outcome symptom screening and management program for better tailored treatment and care of women with metastatic breast cancer.

“The programs funded by these grants are so important for the MBC community and are an important component of our ongoing work,” says Nathalie Baudais, MBC thriver, cancer research advocate, and co-chair of Rethink’s Metastatic Advisory Board. “We know the value of engaging patients and their caregivers in their health and decision-making, and we look forward to seeing how this can be further encouraged and implemented.” 

“We’re proud of our long-standing commitment to the breast cancer community and to support three important projects to improve the quality of care of Canadians living with metastatic breast cancer,” says Andrew Brown, Medical Director, Oncology; Pfizer Canada. “Our collaboration with Rethink Breast Cancer and the participation of members of their MBC Advisory Board added value to the entire process and has given us assurance that the programs we are supporting will truly address the needs of the individuals we are seeking to help.”

“Despite significant advances, metastatic breast cancer remains an incurable disease, and it has a significant impact on all aspects of a person’s life,” says MJ DeCoteau, Executive Director, Rethink Breast Cancer. “This initiative is an important step in continuing to push the status quo and striving to meet the unique needs of the community and improving the lives of all people living with MBC.”

About Pfizer Canada

Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world’s leading biopharmaceutical companies. They apply science and their global resources to improve the health and well-being of Canadians at every stage of life. Their commitment is reflected in everything they do, from their disease awareness initiatives to their community partnerships. To learn more about Pfizer Canada, visit pfizer.ca or follow on LinkedIn, Facebook, Twitter or YouTube.

About Rethink Breast Cancer

Rethink Breast Cancer is a charity known for making positive change by rethinking the status quo when it comes to breast cancer. Their mission is to educate, empower and advocate for young people who are concerned about and affected by breast cancer to help them live better and live longer.  Rethink is a nationally focused organization based in Toronto.